<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations/><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/2DB7ED73-8E89-457A-A395-FAC12F929C1A"><gtr:id>2DB7ED73-8E89-457A-A395-FAC12F929C1A</gtr:id><gtr:name>University of Edinburgh</gtr:name><gtr:department>The Roslin Institute</gtr:department><gtr:address><gtr:line1>Old College</gtr:line1><gtr:line2>South Bridge</gtr:line2><gtr:line3>Mayfield Road</gtr:line3><gtr:line4>Edinburgh</gtr:line4><gtr:postCode>EH8 9YL</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/2DB7ED73-8E89-457A-A395-FAC12F929C1A"><gtr:id>2DB7ED73-8E89-457A-A395-FAC12F929C1A</gtr:id><gtr:name>University of Edinburgh</gtr:name><gtr:address><gtr:line1>Old College</gtr:line1><gtr:line2>South Bridge</gtr:line2><gtr:line3>Mayfield Road</gtr:line3><gtr:line4>Edinburgh</gtr:line4><gtr:postCode>EH8 9YL</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/3332545B-7346-472D-863D-D67DB7F869A8"><gtr:id>3332545B-7346-472D-863D-D67DB7F869A8</gtr:id><gtr:firstName>Thomas</gtr:firstName><gtr:otherNames>M</gtr:otherNames><gtr:surname>Wishart</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/205435A8-741B-4AA1-AB9B-98639E4FD2C6"><gtr:id>205435A8-741B-4AA1-AB9B-98639E4FD2C6</gtr:id><gtr:firstName>Derya Deniz</gtr:firstName><gtr:surname>Ozdemir</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/6A76214C-10A1-4392-98CC-2F8A5BD81CA4"><gtr:id>6A76214C-10A1-4392-98CC-2F8A5BD81CA4</gtr:id><gtr:firstName>Peter</gtr:firstName><gtr:surname>Hohenstein</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=MR%2FM010341%2F1"><gtr:id>9F0C5122-E434-480F-AB68-4F33C6D09A37</gtr:id><gtr:title>beta-catenin Ser45 in development and disease</gtr:title><gtr:status>Active</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>MR/M010341/1</gtr:grantReference><gtr:abstractText>Mutations in the beta-catenin signalling pathway are found in many types of cancer. It is widely assumed that all these mutations activate this pathway. We are interested in the development of Wilms' tumours, kidney cancers found in young children that are the result of normal kidney development before birth going wrong. A subset of these tumours has mutations in beta-catenin. Interestingly, whereas there are four different mutations possible, almost all patients have exactly the same mutation, suggesting this mutation is specifically important for this type of cancer. In the work leading up to this proposal we have made mouse models that carry different mutant copies of beta-catenin, including the mutation found in Wilms' tumours. We found that this mutation resulted in kidney abnormalities that would fit with a role in Wilms' tumours but, surprisingly, this mutation did not seem to activate the protein. Unfortunately, these models were made in a way that differs from the way the gene is mutated in patients, and it is therefore not possible to conclude this mutation will have the same effect in tumours.

In this project we will therefore first make the mutation in exactly the same way as found in human tumours. We will repeat the analyses we have done before on the other model to see if the surprising findings we did are confirmed. We will study the effect of this mutation in mice, with an emphasis on the kidney and neuron / brain.</gtr:abstractText><gtr:technicalSummary>It is assumed that oncogenic mutations found in beta-catenin result in activation of the pathway. We have a strong interest in the early steps in the development of Wilms' tumours, in particular the subset that is caused by loss of WT1 and activation of beta-catenin. Interestingly, almost all cases of Wilms' tumour with mutant beta-catenin carry a mutation affecting the Ser45 residue. To study the reason for this selection we have previously generated several mouse models that express different beta-catenin mutations from the Rosa26 locus. We found that the Ser45 mutant does not have an increased signalling capacity, despite being stabilized at the protein level as expected. Still, the Ser45 mutation has a biological effect on Wt1-deficient kidney mesenchyme cells which were driven a step closer towards Wilms' tumours. This finding suggests a complete new dimension to the role of beta-catenin mutations in cancer. However, the fact that our models express their mutant beta-catenin from Rosa26 means we cannot directly translate these finding to patients. In this project we will therefore generate a Cre-inducible Ser45 mutation in the endogenous mouse beta-catenin gene. We will test its capability to increase target gene transcription in ES cells as we did for the Rosa26 models. In vivo we will activate the expression of the mutant allele through a Cre deleter strain and analyse the phenotype in development and/or postnatal. To study the role of this mutation in Wilms' tumour development we will cross the mice with our kidney mesenchyme-specific Wt1 knockout. We will use genome-wide expression analysis to identify molecular changes that could explain the selection for this mutation in WT1-mutant Wilms' tumours. The mice will be followed for Wilms' tumour development and other phenotypes. Finally, we will specifically analyse any phenotypes in the neuronal system caused by the Ser45 mutation.</gtr:technicalSummary><gtr:potentialImpactText>The proposed project will have a potential impact on the following stake holders.

The academic community working on cancer genetics in general, and Wilms' tumour genetics in particular. The information gained in this project will increase our understanding of cancer genetics, Darwinian selection in tumourigenesis and the roles of specific cancer-related mutations in the origin of tumours.

The health sector. Better understanding of the earlier steps in cancer development will ultimately lead to improvement in cancer treatment options. 

Cancer patients. Better understanding of the origins of cancer and identification of the processes that, when disturbed, lead to cancer development will allow the design of more efficient and more specific therapies. This will result in better treatments with fewer side-effects, leading to a significant increase in quality of life.

General public. As the public pays for MRC-funded research through their taxes there is an obvious right of information on what is done with the money.
 
The pharmaceutical industry. There is an important lack in sufficiently good animal models for cancer. The use of models that are available for design and testing of therapies have in many cases been found not to be predictive for the efficacy of a therapy in patients. As a result too many new drug candidates are failing to make it to the clinic. Models as proposed here that mimic the genetic events in cancer in patients as closely as possible will undoubtedly lead to better and more predictive models for these purposes.

The staff on the project. Biomedical sciences increasingly require a multitude of techniques and approaches to answer a scientific question. The experimental models used become more sophisticated as technical possibilities improve. For both named staff this project will allow the extension of their expertise. For Dr. Ozdemir this project will help to further establish her reputation in the Wilms' tumour and mouse model field. She will be able to increase her expertise in the generation of genetically modified mouse models using the latest technologies, and introduce her to next-generation sequencing approaches. Mrs Sheraz has so far been running the mouse colony of the Hohenstein lab and been involved in developing and optimizing in vitro culture methods for mesenchymal kidney progenitor cells. This project will allow her to become experienced in all steps in the generation and analysis of transgenic mouse models.</gtr:potentialImpactText><gtr:fund><gtr:end>2018-06-30</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2015-02-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>656977</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs/><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>ILAR Roundtable 'gene editing to modify naimal genomes for reserarch - scientific and ethical considerations'</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>9B416C34-78D0-4194-ABDC-EBE32204537A</gtr:id><gtr:impact>Round Table organized by the National Academy of Sciences in the USA to discuss the impact of genome editing on animal use in science.</gtr:impact><gtr:outcomeId>56d42bacd146d6.40703301</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Policymakers/politicians</gtr:primaryAudience><gtr:url>http://nas-sites.org/ilar-roundtable/roundtable-activities/gene-editing-to-modify-animal-genomes-for-research/</gtr:url><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Coming of Age: The Legacy of Dolly at 20 public lecture</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>EB8C2810-8FFB-48E5-8FDA-E0A9786EA9E3</gtr:id><gtr:impact>At a series of public lectures to celebrate the 20th birthday of Dolly the Sheep I discussed kidney research with the public</gtr:impact><gtr:outcomeId>58b46f67da69f1.59612235</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>student talk at high school</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>B6AF21F9-21B2-4B82-B9CE-E9511E527860</gtr:id><gtr:impact>talk at local high school discussing animal use in science in the context of kidney development, kidney stem cells, kidney disease and imaging</gtr:impact><gtr:outcomeId>56d42ab44c4606.41000804</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>in conversation with session on Roslin Open Doors day</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>576F9B6B-CE44-4983-A6C6-0660EA3AF06A</gtr:id><gtr:impact>General public had 'in conversation with' sessions with scientists from The Roslin Institute to discuss their science. I have focused my sessions on the use of animals in research, and in kidney development and disease in particular.</gtr:impact><gtr:outcomeId>56d429be2eefc3.58304400</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Lobbying reception Scottish Parliament</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>02256613-0699-4612-875C-99841C4E448B</gtr:id><gtr:impact>Kidney research UK organized a lobbyng reception in the Scottish parliament to discuss the importance of kidney research with MSPs, patients and other researchers.</gtr:impact><gtr:outcomeId>58b460fe167ce9.63560767</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Policymakers/politicians</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>invited seminar at Crick Institute Mill Hill</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>4C3E9D10-2CA0-4AC8-B771-3441D3944B8A</gtr:id><gtr:impact>invited seminar</gtr:impact><gtr:outcomeId>58b471db33ba28.23729897</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Organiser and speaker at 3rd international workshop on the biology of WT1</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>A959C57F-B0C7-4781-852B-8C8D2257CE33</gtr:id><gtr:impact>Organized the 3 international workshop in the biology of WT1 and spoke on the meeting</gtr:impact><gtr:outcomeId>58b474e939da48.25039729</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Talk at MRC Toxicology Unit, Leicester</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>A931EEAF-38CC-4AE8-BCBC-E7BE4412DD3A</gtr:id><gtr:impact>Invited seminar</gtr:impact><gtr:outcomeId>58b471573bee61.24808285</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>7th course Developmental Biology, Institute Curie, Paris</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>F5DC038D-4BC1-4787-8DB2-5456FF9596A7</gtr:id><gtr:impact>I gave a talk at the 7th international course for developmental biology, organised by the Institue Curiein Paris</gtr:impact><gtr:outcomeId>58b462a1464ff9.72574399</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Postgraduate students</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Consensus Meeting on Renal Progenitors and Kidney Regeneration</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>AC0320DA-6BF9-47DB-877D-C784A510048A</gtr:id><gtr:impact>I gave a talk at this meeting organised to discuss the many different views in the field about renal progenitor cells.</gtr:impact><gtr:outcomeId>58b470cc0c83a9.20171286</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>visit Biomed students Wyoming</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>7446EEFA-3C54-4FA9-9BD1-F70B6663A6E3</gtr:id><gtr:impact>A group of undergrad students from Wyoming visited the institute and I gave a talk about 'being a scientist' and our kidney research in particular</gtr:impact><gtr:outcomeId>58b45fb7c99c00.09371727</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Undergraduate students</gtr:primaryAudience><gtr:year>2017</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Visit Kidney research UK delegation to Edinburgh</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>DD676CC6-FB62-4D61-898B-AF1D6ECFD6C4</gtr:id><gtr:impact>A delegation from Kidney research UK visited Edinburgh to discuss renal research with all kidney researchers</gtr:impact><gtr:outcomeId>58b461b95dca76.43841717</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Other audiences</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>hosting seminar Andy McMahon</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>3B6DAD21-FA01-4422-AF9A-86F96EC3637D</gtr:id><gtr:impact>hosted an external seminar in the institute</gtr:impact><gtr:outcomeId>58b4740c74efa1.68473258</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Talk at Nephrotools meeting</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>F31CF2DA-C64C-4A8E-9FCF-494B52ABBA23</gtr:id><gtr:impact>Ta\lk at a meeting of the EU funded Nephrotools consortium</gtr:impact><gtr:outcomeId>58b47469ba4373.96886131</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>regenerative Medicine Therapy network development meeting</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>DEC34507-738F-4055-BC95-624E16330A29</gtr:id><gtr:impact>A meeting to discuss the development of a national network on Renal Regenerative Medicine with the support of Kidney Research UK</gtr:impact><gtr:outcomeId>58b46d0bd259b4.48172313</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Welcoming committee</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>20A1F267-DD0A-4FAA-A0F4-D51ED617DE65</gtr:id><gtr:impact>At the open doors day Roslin Institute I was welcoming visitors to the building, while my lab was demonstrating the culture of embryonic mouse kidneys on our time-lapse imaging system</gtr:impact><gtr:outcomeId>58b47354872626.78575001</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>hosting seminar Robert Kelsh</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>EF24DABC-64F7-4E9A-A289-8363D1E95C7D</gtr:id><gtr:impact>hosted external seminar from Robert Kelsh</gtr:impact><gtr:outcomeId>58b4752e90d0f8.36262319</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>18000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>PhD student funded from MSc biomedical sciences</gtr:description><gtr:end>2017-10-02</gtr:end><gtr:fundingOrg>University of Edinburgh</gtr:fundingOrg><gtr:id>D8DB5EF9-D6EF-4781-968E-6B21B12212FF</gtr:id><gtr:outcomeId>56d85d88f351b9.18436265</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2014-11-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>These cells carry a V5 epitope tag on the N-terminus of the endogenous beta-catenin gene. They were an intermediate step in the generation of the delSer45 mouse model in this proposal.</gtr:description><gtr:id>81D07D7F-E310-4D73-907B-9E42B45115A3</gtr:id><gtr:impact>These cells can be used for a variety of in vitro proteomic approaches and could be turned into mice for in vivo proteomics (not part of this proposal)</gtr:impact><gtr:outcomeId>56d85c7bb1aa37.73518848</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>V5-beta catenin mouse ES cells</gtr:title><gtr:type>Cell line</gtr:type></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>This cell line was made as a control for the delSer45 mutation which was an intermediate step in the generation of the delSer45 mice from this project.</gtr:description><gtr:id>0BE5ABD5-A627-4E6A-BA83-923551B0D421</gtr:id><gtr:impact>These ES cells can be used to generate Ser33Tyr mutatn beta-catenin m ice (not part of this proposal) and can be used as an in vitro system for further analysis in their own right.</gtr:impact><gtr:outcomeId>56d85c106d5d19.14136467</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>mouse embryonic stem cells with Ser33Tyr mutation in beta-catenin</gtr:title><gtr:type>Cell line</gtr:type></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>We generated mouse ES cells heterozygous and homozygous for the delSer45 mutation in the endogenous beta-catenin gene that we currently are analysing</gtr:description><gtr:id>8F0722F2-CA30-4D8C-A32F-D4ABFCF21AE1</gtr:id><gtr:impact>This ES line is an intermediate step in the generation of delSer45 knock-in mice we proposed in the project, and which can be used as an experimental in vitro system for further analysis</gtr:impact><gtr:outcomeId>56d85aa802fe38.05046612</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>mouse embryonic stem cells with constitutive delSer45 mutation in beta-catenin</gtr:title><gtr:type>Cell line</gtr:type></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>37B81CB6-1BFB-49A4-B9A2-F3865DA6DBF8</gtr:id><gtr:title>Refuting the hypothesis that semaphorin-3f/neuropilin-2 exclude blood vessels from the cap mesenchyme in the developing kidney.</gtr:title><gtr:parentPublicationTitle>Developmental dynamics : an official publication of the American Association of Anatomists</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e81c6c3221ab6ebfa513dc0dfc5c601e"><gtr:id>e81c6c3221ab6ebfa513dc0dfc5c601e</gtr:id><gtr:otherNames>Munro DAD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1058-8388</gtr:issn><gtr:outcomeId>5a86ae2ab9b5f0.61081090</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>568DA0F4-D8A3-4BD1-A061-9906B6D5E0E3</gtr:id><gtr:title>Molecular analysis of axonal-intrinsic and glial-associated co-regulation of axon degeneration.</gtr:title><gtr:parentPublicationTitle>Cell death &amp; disease</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d78858e9888086aacb016e3025d37f4c"><gtr:id>d78858e9888086aacb016e3025d37f4c</gtr:id><gtr:otherNames>Catenaccio A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:outcomeId>5a748d3c378f91.68518955</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1D5A2DBB-8E59-4D81-BF31-1EDDE278F49B</gtr:id><gtr:title>Proteomic profiling of neuronal mitochondria reveals modulators of synaptic architecture.</gtr:title><gtr:parentPublicationTitle>Molecular neurodegeneration</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/855c4a089ec5c5e7721a1cfcd947afe6"><gtr:id>855c4a089ec5c5e7721a1cfcd947afe6</gtr:id><gtr:otherNames>Graham LC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1750-1326</gtr:issn><gtr:outcomeId>5a2fd6a5b0ae14.27095663</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F6B7B34C-2271-41E2-A486-EE2C0E48FB34</gtr:id><gtr:title>Size doesn't matter; in the stroma, little things make all the difference.</gtr:title><gtr:parentPublicationTitle>Kidney international</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e8edda5e3b399b16da1d2d651a54cace"><gtr:id>e8edda5e3b399b16da1d2d651a54cace</gtr:id><gtr:otherNames>Ozdemir DD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0085-2538</gtr:issn><gtr:outcomeId>56d42622032a37.82964197</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>79959F92-F30F-495E-89A2-1E6928D17A80</gtr:id><gtr:title>Cycles of vascular plexus formation within the nephrogenic zone of the developing mouse kidney.</gtr:title><gtr:parentPublicationTitle>Scientific reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e81c6c3221ab6ebfa513dc0dfc5c601e"><gtr:id>e81c6c3221ab6ebfa513dc0dfc5c601e</gtr:id><gtr:otherNames>Munro DAD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>2045-2322</gtr:issn><gtr:outcomeId>5a86ae2b14c604.09534628</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7E4C4D4D-52B0-4325-A5D1-89011E532198</gtr:id><gtr:title>Commonality amid diversity: Multi-study proteomic identification of conserved disease mechanisms in spinal muscular atrophy.</gtr:title><gtr:parentPublicationTitle>Neuromuscular disorders : NMD</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5e3c3cbaef210baf2d0445d801f7729d"><gtr:id>5e3c3cbaef210baf2d0445d801f7729d</gtr:id><gtr:otherNames>Fuller HR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0960-8966</gtr:issn><gtr:outcomeId>585d3536280756.58734564</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>34BCFD92-AA82-4C2F-8E8D-2F989F809261</gtr:id><gtr:title>Understanding the molecular consequences of inherited muscular dystrophies: advancements through proteomic experimentation.</gtr:title><gtr:parentPublicationTitle>Expert review of proteomics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5e3c3cbaef210baf2d0445d801f7729d"><gtr:id>5e3c3cbaef210baf2d0445d801f7729d</gtr:id><gtr:otherNames>Fuller HR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1478-9450</gtr:issn><gtr:outcomeId>585d37708099d4.57445179</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6AF80560-AFCC-4F12-A009-2DABC1D98A9B</gtr:id><gtr:title>Bridging the gap: large animal models in neurodegenerative research.</gtr:title><gtr:parentPublicationTitle>Mammalian genome : official journal of the International Mammalian Genome Society</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cf025bedaff339c169c8bcacaf9eebc7"><gtr:id>cf025bedaff339c169c8bcacaf9eebc7</gtr:id><gtr:otherNames>Eaton SL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0938-8990</gtr:issn><gtr:outcomeId>5a2fd75a7e0dc6.33253652</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5D311F76-F538-40A0-BCE2-E7F06F125A02</gtr:id><gtr:title>Deducing the stage of origin of Wilms' tumours from a developmental series of Wt1-mutant mice.</gtr:title><gtr:parentPublicationTitle>Disease models &amp; mechanisms</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f8602f44e42021651bd556f52b0eb8f5"><gtr:id>f8602f44e42021651bd556f52b0eb8f5</gtr:id><gtr:otherNames>Berry RL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1754-8403</gtr:issn><gtr:outcomeId>56d426219dd808.87418153</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D8C8C2B4-A841-4020-B779-771FE3CAA995</gtr:id><gtr:title>The yin and yang of kidney development and Wilms' tumors.</gtr:title><gtr:parentPublicationTitle>Genes &amp; development</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/09120cfed3e1705c5ff0a23a581ced62"><gtr:id>09120cfed3e1705c5ff0a23a581ced62</gtr:id><gtr:otherNames>Hohenstein P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0890-9369</gtr:issn><gtr:outcomeId>588b71809e3c59.73379312</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>38026842-7BD0-414F-BDB2-C85F6B7DEFB7</gtr:id><gtr:title>Sideroflexin 3 is an a-synuclein-dependent mitochondrial protein that regulates synaptic morphology.</gtr:title><gtr:parentPublicationTitle>Journal of cell science</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bf76faabd98af1661de3c6eee9d86a22"><gtr:id>bf76faabd98af1661de3c6eee9d86a22</gtr:id><gtr:otherNames>Amorim IS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0021-9533</gtr:issn><gtr:outcomeId>588b6e2c4353d5.44224784</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>66D833F0-449F-42D2-8FC1-A94036594C9B</gtr:id><gtr:title>Analysis of gene expression in the nervous system identifies key genes and novel candidates for health and disease.</gtr:title><gtr:parentPublicationTitle>Neurogenetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/008748be7043cfa49caded1c3f3b9713"><gtr:id>008748be7043cfa49caded1c3f3b9713</gtr:id><gtr:otherNames>Carpanini SM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1364-6745</gtr:issn><gtr:outcomeId>5a2fd6484dc8a4.50148269</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>90EED84B-AD51-4A4A-A5D9-97299FCEFD14</gtr:id><gtr:title>Quantitative imaging of tissue sections using infrared&amp;nbsp;scanning technology.</gtr:title><gtr:parentPublicationTitle>Journal of anatomy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cf025bedaff339c169c8bcacaf9eebc7"><gtr:id>cf025bedaff339c169c8bcacaf9eebc7</gtr:id><gtr:otherNames>Eaton SL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0021-8782</gtr:issn><gtr:outcomeId>588b71d404ed56.04125477</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AAB71113-195C-4039-8E63-51589D568FC1</gtr:id><gtr:title>2- and 3-dimensional synthetic large-scale de novo patterning by mammalian cells through phase separation.</gtr:title><gtr:parentPublicationTitle>Scientific reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e6088eebb925253626086ac431a79208"><gtr:id>e6088eebb925253626086ac431a79208</gtr:id><gtr:otherNames>Cachat E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2045-2322</gtr:issn><gtr:outcomeId>56d426215306c4.15172477</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B0EBD4B4-C8FE-4068-9199-BAFBE7BDC57D</gtr:id><gtr:title>Proteomic Profiling of Cranial (Superior) Cervical Ganglia Reveals Beta-Amyloid and Ubiquitin Proteasome System Perturbations in an Equine Multiple System Neuropathy.</gtr:title><gtr:parentPublicationTitle>Molecular &amp; cellular proteomics : MCP</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fee617e4de7f0b33b6245c3afaabb01f"><gtr:id>fee617e4de7f0b33b6245c3afaabb01f</gtr:id><gtr:otherNames>McGorum BC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1535-9476</gtr:issn><gtr:outcomeId>585d5753a75c34.93132919</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>585EF5A7-3BD0-49A7-B5EC-2A770064FC65</gtr:id><gtr:title>Hypomorphic conditional deletion of E11/Podoplanin reveals a role in osteocyte dendrite elongation.</gtr:title><gtr:parentPublicationTitle>Journal of cellular physiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2a57ef0b0eae37b4dd694f0b683a15a0"><gtr:id>2a57ef0b0eae37b4dd694f0b683a15a0</gtr:id><gtr:otherNames>Staines KA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0021-9541</gtr:issn><gtr:outcomeId>5a86aea0b31dc2.79727454</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EA025711-B421-40FB-9BDB-C3C05C4637C2</gtr:id><gtr:title>WT1 expression in breast cancer disrupts the epithelial/mesenchymal balance of tumour cells and correlates with the metabolic response to docetaxel.</gtr:title><gtr:parentPublicationTitle>Scientific reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/75c315f2aea28e61922be0ee0cd5738b"><gtr:id>75c315f2aea28e61922be0ee0cd5738b</gtr:id><gtr:otherNames>Artibani M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>2045-2322</gtr:issn><gtr:outcomeId>5a34eb97d9dbd9.80084655</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>087CE5B0-0585-47DB-A7F3-135758A78AFC</gtr:id><gtr:title>WT1 Is Necessary for the Proliferation and Migration of Cells of Renin Lineage Following Kidney Podocyte Depletion.</gtr:title><gtr:parentPublicationTitle>Stem cell reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bbfe1a141eaccd4c94a155ed1c3a50b5"><gtr:id>bbfe1a141eaccd4c94a155ed1c3a50b5</gtr:id><gtr:otherNames>Kaverina NV</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>2213-6711</gtr:issn><gtr:outcomeId>5a86ae5d36eab0.07753875</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8066B882-B5E6-478E-B753-E9A8B089351C</gtr:id><gtr:title>Transcription factor Wilms' tumor 1 regulates developmental RNAs through 3' UTR interaction.</gtr:title><gtr:parentPublicationTitle>Genes &amp; development</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/15c64b9b091b74284f275a083a68e93f"><gtr:id>15c64b9b091b74284f275a083a68e93f</gtr:id><gtr:otherNames>Bharathavikru R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0890-9369</gtr:issn><gtr:outcomeId>5a86adb3c601f7.64436682</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">MR/M010341/1</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>7C58A707-1BF6-4573-A44F-30B271C80813</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Cancer</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>